Cargando…

Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment

Detalles Bibliográficos
Autores principales: Villani, Alessia, Fabbrocini, Gabriella, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270927/
https://www.ncbi.nlm.nih.gov/pubmed/32244017
http://dx.doi.org/10.1016/j.jaad.2020.03.057
_version_ 1783541989560549376
author Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
author_facet Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
author_sort Villani, Alessia
collection PubMed
description
format Online
Article
Text
id pubmed-7270927
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-72709272020-06-05 Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano J Am Acad Dermatol JAAD Online by the American Academy of Dermatology, Inc. 2020-06 2020-03-31 /pmc/articles/PMC7270927/ /pubmed/32244017 http://dx.doi.org/10.1016/j.jaad.2020.03.057 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle JAAD Online
Villani, Alessia
Fabbrocini, Gabriella
Costa, Claudia
Scalvenzi, Massimiliano
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title_full Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title_fullStr Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title_full_unstemmed Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title_short Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment
title_sort patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (covid-19) period: management and adherence to treatment
topic JAAD Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270927/
https://www.ncbi.nlm.nih.gov/pubmed/32244017
http://dx.doi.org/10.1016/j.jaad.2020.03.057
work_keys_str_mv AT villanialessia patientswithadvancedbasalcellcarcinomasintreatmentwithsonichedgehoginhibitorsduringthecoronavirusdisease2019covid19periodmanagementandadherencetotreatment
AT fabbrocinigabriella patientswithadvancedbasalcellcarcinomasintreatmentwithsonichedgehoginhibitorsduringthecoronavirusdisease2019covid19periodmanagementandadherencetotreatment
AT costaclaudia patientswithadvancedbasalcellcarcinomasintreatmentwithsonichedgehoginhibitorsduringthecoronavirusdisease2019covid19periodmanagementandadherencetotreatment
AT scalvenzimassimiliano patientswithadvancedbasalcellcarcinomasintreatmentwithsonichedgehoginhibitorsduringthecoronavirusdisease2019covid19periodmanagementandadherencetotreatment